As many teens and adults in the US restart their social lives, parents of children under the age of 12 wonder when their kids will also be able to experience the freedom that comes with vaccination.
Though currently approved COVID-19 vaccines effectively provide immunity against the virus, it's unclear how long that protection will last.
Various companies use different ingredients and different delivery systems in their COVID-19 vaccines. Researchers are investigating whether it's better for individuals to mix what's available.
The COVID-19 vaccines are a smash success. But that doesn't mean they keep every vaccinated person completely free of the coronavirus.
The CDC and FDA said the benefits of the Johnson & Johnson vaccine far outweigh the low risk of developing rare blood clots and lifted a pause on the vaccine's use. A doctor explains.
It's normal for different people to mount stronger or weaker immune responses to a vaccine, but post-shot side effects won't tell you which you are.
The one-dose vaccine developed by Johnson & Johnson is temporarily halted because of potentially serious blood clots seen in six women. An immunologist explains what this means for you.
The one-dose vaccine developed by Johnson & Johnson is temporarily halted because of potentially serious blood clots seen in six women. An immunologist explains what this means for you.
The vaccine rollout is underway, but what happens if there is a supply disruption? Would it be feasible to change strategy and give more people a first dose? An expert analyzes the data.
So far, most vaccines in the US are mRNA vaccines. These represent a new technology and are likely to take over the vaccine world. But how do they work? What are their weaknesses? Five experts explain.
/
6
